Dabur Research Foundation

Medical research organization

(Learn how and when to remove this message)

Dabur Research Foundation

Founded	1979
Headquarters	Sahibabad, Ghaziabad – 201010 (UP) , India
Parent	Dabur India Limited
Website	daburresearch.in

Dabur Research Foundation (DRF) is an Indian contract research organization offering pre-clinical services in drug discovery and development. It was established in 1979 to spearhead the research and development activities of Dabur, India's largest Ayurvedic medicine manufacturer.

References

Articles about International Finance Corporation – Economic Times
BioSpectrumIndia – the business of biotech – Customer relationships in a competitive market
Elephant Capital buys stake in ClinTec Intl for Rs 58 cr
Cosmetics testing kills 3.9 million animals - BioSpectrum Asia
Burmans plan Rs 925-crore healthcare fund
Dabur to re-expand its pharma research

Review of Literature

Madaan, Alka; Singh, Pratibha; Awasthi, Anshumali; Verma, Ritu; Singh, Anu T.; Jaggi, Manu; Mishra, Shiva Kant; Kulkarni, Sadanand; Kulkarni, Hrishikesh (2012). "Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel". Clinical and Translational Oncology. 15 (1): 26–32. doi:10.1007/s12094-012-0883-2. PMID 22855169. S2CID 25812380.
Kumar, Vivek; Madaan, Alka; Sanna, Vinod K.; Vishnoi, Manupriya; Joshi, Narendra; Singh, Anu T.; Jaggi, Manu; Sharma, Pramod K.; et al. (2009). "Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives". Journal of Enzyme Inhibition and Medicinal Chemistry. 24 (5): 1169–78. doi:10.1080/14756360802696802. PMID 19555167. S2CID 35892078.
Bansal, Tripta; Jaggi, Manu; Khar, Roop K; Talegaonkar, Sushama (2009). "Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy". Journal of Pharmacy & Pharmaceutical Sciences. 12 (1): 46–78. CiteSeerX 10.1.1.557.474. doi:10.18433/J3RC77. PMID 19470292.